Page 186 - Read Online

mitotic figures, necrosis and endothelial proliferation, Rosenblum M, Mikkelsen T. Can permeability measurements add
correlated to the subsequent clinico-radiological to blood volume measurements in differentiating tumefactive
profile, glioma co-existing with TDL could be reliably demyelinating lesions from high grade gliomas using perfusion CT?
J Neurooncol 2010;97:383‑8.
excluded. [11] Our case highlights the importance of 6. Roemer SF, Scheithauer BW, Varnavas GG, Lucchinetti CF.
meticulous radiopathological inputs required into Tumefactive demyelination and glioblastoma: a rare collision lesion.
analysis of butterfly multifocal lesions that is the key Clin Neuropathol 2011;30:186‑91.
to guide subsequent management of an evidently 7. Altintas A, Petek B, Isik N, Terzi M, Bolukbasi F, Tavsanli M, Saip S,
Boz C, Aydin T, Arici‑Duz O, Ozer F, Siva A. Clinical and radiological
treatable condition. characteristics of tumefactive demyelinating lesions: follow‑up study.
Mult Scler 2012;18:1448‑53.
REFERENCES 8. Saini J, Chatterjee S, Thomas B, Kesavadas C. Conventional
and advanced magnetic resonance imaging in tumefactive
demyelination. Acta Radiol 2011;52:1159‑68.
1. Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, 9. Kepes JJ. Large focal tumor‑like demyelinating lesions of the brain:
Slone HW, Kehagias D. Lesions of the corpus callosum: MR imaging
and differential considerations in adults and children. AJR Am J intermediate entity between multiple sclerosis and acute disseminated
encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18‑27.
Roentgenol 2002;179:251‑7.
2. Kobayashi M, Shimizu Y, Shibata N, Uchiyama S. Gadolinium 10. Neelima R, Krishnakumar K, Nair MD, Kesavadas C, Hingwala DR,
enhancement patterns of tumefactive demyelinating lesions: Radhakrishnan VV, Nair SS. Tumefactive demyelinating lesions:
a clinicopathological correlative study. Indian J Pathol Microbiol
correlations with brain biopsy findings and pathophysiology.
J Neurol 2014;261:1902‑10. 2012;55:496‑500.
3. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, 11. Donev K, Scheithauer BW. Pseudoneoplasms of the nervous system.
Arch Pathol Lab Med 2010;134:404‑16.
Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ,
Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W.
Clinical and radiographic spectrum of pathologically confirmed
tumefactive multiple sclerosis. Brain 2008;131:1759‑75. Cite this article as: Menon R, Thomas B, Easwer HV, Sandhyamani S, Nair A,
4. Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity Nair M. A clinically isolated syndrome: butterfly glioma mimic. Neuroimmunol
Neuroinflammation 2015;2(3):174-8.
associated with ring‑enhancing brain lesions can help to differentiate
pathology. Neuroradiology 2006;48:143‑9. Source of Support: Nil. Conflict of Interest: No.
5. Jain R, Ellika S, Lehman NL, Scarpace L, Schultz LR, Rock JP, Received: 30-10-2014; Accepted: 11-02-2015

178 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 PB